211 related articles for article (PubMed ID: 10255868)
1. Delegations of authority and organization; new drug applications--Food and Drug Administration. Final rule.
Fed Regist; 1982 Jun; 47(120):26822-3. PubMed ID: 10255868
[TBL] [Abstract][Full Text] [Related]
2. Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule.
Fed Regist; 1993 Apr; 58(61):17093-4. PubMed ID: 10125229
[TBL] [Abstract][Full Text] [Related]
3. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
Fed Regist; 1991 Nov; 56(225):58758-9. PubMed ID: 10115699
[TBL] [Abstract][Full Text] [Related]
4. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
[TBL] [Abstract][Full Text] [Related]
5. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
Fed Regist; 1991 Nov; 56(225):58758. PubMed ID: 10115698
[TBL] [Abstract][Full Text] [Related]
6. Delegations of authority and organization; National Childhood Vaccine Injury Act of 1986--FDA. Final rule.
Fed Regist; 1993 Apr; 58(61):17105-6. PubMed ID: 10125232
[TBL] [Abstract][Full Text] [Related]
7. Investigational new drug applications; clinical holds; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Dec; 63(239):68710-2. PubMed ID: 10187560
[TBL] [Abstract][Full Text] [Related]
8. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
[TBL] [Abstract][Full Text] [Related]
9. Investigational new drug applications; clinical holds--FDA. Direct final rule.
Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
[TBL] [Abstract][Full Text] [Related]
10. Delegations of authority and organization--FDA. Final rule.
Fed Regist; 1998 Apr; 63(72):18314-7. PubMed ID: 10179312
[TBL] [Abstract][Full Text] [Related]
11. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
[TBL] [Abstract][Full Text] [Related]
12. Delegations of authority and organization; Center for Devices and Radiological Health. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Feb; 64(21):4964-5. PubMed ID: 10557613
[TBL] [Abstract][Full Text] [Related]
13. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
Fed Regist; 1991 Oct; 56(197):51169-70. PubMed ID: 10115059
[TBL] [Abstract][Full Text] [Related]
14. Environmental assessments and findings of no significant impact--FDA. Notice.
Fed Regist; 1998 May; 63(95):27300-3. PubMed ID: 10179346
[TBL] [Abstract][Full Text] [Related]
15. Delegations of authority and organization; Ryan White Comprehensive AIDS Resources Emergency Act of 1990--FDA. Final rule.
Fed Regist; 1991 Aug; 56(167):42527. PubMed ID: 10113840
[TBL] [Abstract][Full Text] [Related]
16. Administrative practices and procedures; internal agency review of decisions; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 Jun; 63(115):32772-4. PubMed ID: 10180279
[TBL] [Abstract][Full Text] [Related]
17. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule.
Fed Regist; 1998 May; 63(91):26127-9. PubMed ID: 10179335
[TBL] [Abstract][Full Text] [Related]
18. Administrative practices and procedures; internal review of agency decisions---FDA. Direct final rule.
Fed Regist; 1998 Jun; 63(115):32733-5. PubMed ID: 10180278
[TBL] [Abstract][Full Text] [Related]
19. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
[TBL] [Abstract][Full Text] [Related]
20. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Sep; 73(189):56487-91. PubMed ID: 18985960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
